<DOC>
	<DOCNO>NCT00034853</DOCNO>
	<brief_summary>To obtain safety , efficacy , pharmacokinetic dose information meloxicam oral suspension child Juvenile Rheumatoid Arthritis ( JRA )</brief_summary>
	<brief_title>Meloxicam Mobic Juvenile Rheumatoid Arthritis ( JRA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>diagnosis juvenile idiopathic arthritis ( JIA ) International League Associations Rheumatology ( ILAR ) criterion ; pauciarthritic , extended pauciarthritic , polyarthritic current course disease ; active arthritis least 2 joint least 2 abnormal variable 5 remain core set parameter require nonsteroidal antiinflammatory drug ( NSAIDs ) child age 217 year systemic course juvenile idiopathic arthritis rheumatic condition include inclusion criterion ; clinical finding abnormal clinically relevant lab ( due JIA ) could interfere conduct clinical trial weight 9 kg less pregnancy breast feeding female childbearing potential sexually active use adequate contraception least 3 mos prior duration study history bleed disorder , gastrointestinal bleeding , cerebrovascular bleeding peptic ulcer past 6 month 1 disease modify antirheumatic drug ( DMARD ) change DMARD 3 month prior change corticosteroid 1 month prior systemic corticosteroid great 10 mg/d , hydroxychloroquine great 10/mg/d , cyclosporine great 5 mg/kg/d. , methotrexate great 15 mg/m2/wk , cytotoxic agent , gold , Dpenicilamine , sulfasalazine , glucosamine , investigational product etanercept 1 month prior ; infliximab 2 month prior ; intraarticular corticosteroid 1 month prior patient require concomitant NSAID include topical ( exclude ophthalmic ) requirement use NSAIDs , anticoagulant , phenothiazine , lithium , ACTH insufficient effect intolerability naproxen meloxicam know suspected hypersensitivity trial med excipients requirement chronic H2 antagonist history asthma , nasal polyp , angioneurotic edema , urticaria aspirin NSAIDs plan surgical procedure study investigational drug exposure trial within 30 day ( 6 half life , whichever great ) prior previous participation trial patient know drug alcohol abuse patient , parent legal representative unable understand comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>